Diamond Hill Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Diamond Hill Capital Management's GILD Position: Q4 2021 in Review
Diamond Hill Capital Management sold out of Gilead Sciences (GILD) in Q4 2021, closing a stake of 2,728,609 shares — an estimated $191M sold.
Diamond Hill Capital Management first reported a position in GILD in Q4 2015 and held it in 17 quarters. The position peaked at $191M in Q3 2021. 1,681 funds tracked by Wall St. Rank hold GILD as of Q4 2021.
- Diamond Hill Capital Management reported no remaining Gilead Sciences position as of Q4 2021 after selling out during the quarter.
- Diamond Hill Capital Management sold 2,728,609 Gilead Sciences shares in Q4 2021, an estimated $191M.
- Diamond Hill Capital Management first reported a position in Gilead Sciences in Q4 2015 and held it in 17 quarters.
- Diamond Hill Capital Management's Gilead Sciences position peaked at $191M in Q3 2021.
- 1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.
Based on Diamond Hill Capital Management's 13F filing for Q4 2021, filed 8 Feb 2022.